Industry Press Releases

12th Annual Biomarkers Congress

Thursday, Sep 29, 2016

Registration is Open. The meeting place for over 250 Biomarkers Discovery and Development, Clinical Biomarkers, Companion Diagnostics and Personalised Medicine Attendees...

Bringing in voices from some of the most senior industry and scientific thought leaders from Eisai, Novimmune, Immunocore, Bayer, Biogen, Johnson and Johnson, Novartis, Roche and FNIH, Oxford Global proudly presents the 12th Annual Biomarkers Congress in discussing the latest areas in Biomarkers in Discovery and Validation, Precision Medicine, Diagnostics development and Clinical Development.

The congress will be held on 21-22 February 2017, Manchester, UK.

Our renowned biomarkers congress showcases world-class speakers discussing key innovations of biomarker research in discovery and development, companion diagnostics, data management and analytics, innovative biology, precision medicine and clinical biomarkers.

This year, the featured focus is on Oncology, Immune-oncology, Neurological, Cardiovascular, Inflammatory, Infectious & Rare Diseases.

Download the conference agenda here >>

Alternatively contact Danielle Dalby on +44 1865 248455


Driving Precision Medicine and Advancing Clinical Data
Register for free today >>

Exosome Biomarkers and Diagnostics De-velopment
Register for free today >>

Initiatives and Projects of FNIH and The Global Biomarkers Consortium
Register for free today>>

Notes to editors:

1. Danielle Dalby, Senior Marketing Manager. Phone +44(0) 1865 248455 e-mail
2. Oxford Global Conferences produce cutting edge congresses and summits for the Life Sciences Industry.
3. Oxford Global Conferences Ltd. Phone +44(0) 1865 248455, Fax +44(0) 1865 250985, , Web:

Other Press Releases